Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
Portfolio Pulse from Avi Kapoor
Wall Street's most accurate analysts have provided their views on three high-dividend yielding health care stocks: Pfizer Inc. (PFE), Gilead Sciences, Inc. (GILD), and Patterson Companies, Inc. (PDCO). Pfizer's dividend yield is 6.40%, with mixed analyst ratings and a recent dividend declaration. Gilead has a 4.59% dividend yield, with analysts adjusting price targets downward. Patterson Companies, with a 3.97% yield, has seen price target adjustments and announced a significant stock buyback and a quarterly dividend.
April 25, 2024 | 11:54 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Gilead Sciences, Inc. has a 4.59% dividend yield, with recent price target adjustments by analysts and an upcoming financial results announcement.
The adjustments in price targets and the anticipation of Q1 financial results may have a neutral impact, as positive earnings could offset the negative sentiment from lowered price targets.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
Patterson Companies, Inc., with a 3.97% dividend yield, has seen price target adjustments and announced a significant stock buyback and quarterly dividend.
The announcement of a significant stock buyback and a steady dividend could signal confidence from management, potentially positively impacting the stock price in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Pfizer Inc. has a dividend yield of 6.40%, with recent analyst ratings from Guggenheim and TD Cowen and a declared second-quarter dividend.
The recent dividend declaration and mixed analyst ratings suggest a potentially positive short-term impact on Pfizer's stock, as dividends may attract investors.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90